Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(31 sites)
Austria
Landeskrankenhaus Feldkirch, Feldkirch Medical University Graz, Graz Bulgaria
Medical Center Unimed EOOD, Sevlievo Czechia
Fakultni nem. u sv. Anny v Brne, Brno, Brno The Institute for the Care of Mother and Child, Prague France
Deaconess Hospital Group Croix Saint - Simon, Paris, France Hospital Bichat - Claude Bernard, Paris, France CHU Rennes - Hospital Pontchaillou, Rennes Germany
Heidelberg University, Medical Faculty Mannheim, Department of surgery, Mannheim Italy
IRCCS Ospedale San Raffaele, San Donato Milanese Japan
Hokkaido Railway Company JR Sapporo Hospital, Sapporo, Hokkaido Tsujinaka Hospital, Coloproctological Surgery, Chiba Teikyo University Chiba Medical Center, Chiba Hiroshima Memorial Hospital, Hiroshima Matsushima Hospital, Kanagawa Coloproctology Center Takano Hospital, Kumamoto Japan Post Kyoto Teishin Hospital, Kyoto Jichi Medical University Hospital, Tochigi Juntendo University Hospital, Tokyo Poland
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie, Krakow Spain
Corporacio Sanitaria Parc Tauli, Barcelona Hospital de Mataro, Mataró Hosp. General Universitario Morales Meseguer, Murcia Luis Garcia Florez, Oviedo Sweden
Skånes Universitetssjukhus, Malmo, Malmo, Sweden Östersund sjukhus, Kirurgiska kliniken, Östersund, Sweden Danderyd Sjukhus, Danderyd United Kingdom
St. Mary's Hospital, London